Jump to main content

yr 〜
yr

Search results 2

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15
Digital博士論文障害者向け資料あり
Fujinaga, Yukihisa, Kawaratani, Hideto, Kaya, Daisuke, Tsuji, Yuki, Ozutsumi, Takahiro, Furukawa, Masanori, Kitagawa, Koh, Sato, Shinya, Nishimura, Norihisa, Sawada, Yasuhiko, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-08-04International journal of molecular sciences
National Diet Library
  • Subject Headinghepatic fibrosis rifaximin ARB metabolic syndrome NASH
  • Note (General)... cells (HSCs). Rifaximin, a nonabsorbab......bining ARB and rifaximin administration......ing an ARB and rifaximin was evaluated ......or-β and TLR4. Rifaximin reduced intest......tal endotoxin. Rifaximin directly affec...... of an ARB and rifaximin showed a stron...... HSCs, whereas rifaximin improves hepat......on of ARBs and rifaximin may be a promising therapy fo...

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
Digital博士論文
Fujinaga, Yukihisa, Kawaratani, Hideto, Kaya, Daisuke, Tsuji, Yuki, Ozutsumi, Takahiro, Furukawa, Masanori, Kitagawa, Koh, Sato, Shinya, Nishimura, Norihisa, Sawada, Yasuhiko, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-08-04International journal of molecular sciences21 15p.Article No.5589-
Available onlineOther Libraries in Japan
  • Subject Headinghepatic fibrosis rifaximin ARB metabolic syndrome NASH
  • Note (General)... cells (HSCs). Rifaximin, a nonabsorbab......bining ARB and rifaximin administration......ing an ARB and rifaximin was evaluated ......or-β and TLR4. Rifaximin reduced intest......tal endotoxin. Rifaximin directly affec...... of an ARB and rifaximin showed a stron...... HSCs, whereas rifaximin improves hepat......on of ARBs and rifaximin may be a promising therapy fo...

Reached to the end of result.

RSS